Newsroom

Newsroom

Accessing Genomic Alternations in Chronic Lymphocytic Leukemia Using an NGS-Based Comprehensive Genomic Profiling Assay

Literature
Read More

Oncology Clinical Trials During a Pandemic

Blog
Read More

Using multiplexed immunofluorescence to quantitatively analyze myeloid derived suppressor cells (MDSCs) in relation to tertiary lymphoid structures (TLS) in bladder cancer

Literature
Read More

Identification of lung cancer mutational signatures and tumor drivers associated with specific bimodal PD-L1/TMB status

Literature
Read More

It’s a Great Clinical Trial Assay

Blog
Read More

Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy

Literature
Read More

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests

Press Release
Read More

NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients